Hints and tips:
Related Special Reports
...The projected decline in housebuilding poses a challenge to both main political parties ahead of a general election, expected this year, in which housing will be a big issue....
...“We can see a resurgence in London back to pre-pandemic levels, and a general increase in the popularity of cities among buyers,” said Tim Bannister, Rightmove’s director of property data....
...GIC took a 25 per cent stake in CitizenM five years ago in a deal that valued the business at €2bn including debt....
...A spokesperson for Kulibayev said the Sunninghill Park deal was “a commercial, arm’s-length transaction....
...a day....
...“They can go to [the] website, they can get the information they need, they can be linked to a prescriber and then a pharmacy, and do all those things independent of a primary care provider.”...
...Britishvolt’s plan to build a “gigafactory” for electric vehicle batteries on the site of a former power station had been symbolic of the UK’s efforts to compete in high-tech automotive manufacturing, before...
...At the time, the ECB sent a strong signal that it could consider rate cuts at its next meeting in June. UK: The Office for National Statistics will release its latest figures on UK GDP....
...A long-awaited approval decision on Moderna’s second commercial product after its Covid-19 jab has been delayed by several weeks, the US biotech said on Friday....
...In a private email published by Sabadell on Wednesday, the BBVA chair said the bank had “no room” to improve the offer....
...In a statement on Wednesday, chair Tim Martin said: “Traditional ales, which were very slow in the aftermath of the lockdowns, are increasing momentum,” adding that “the gods of fashion have smiled upon...
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise the treatment for...
...The move sets up a multibillion-euro battle in a country where there have been just a handful of hostile bids over the past quarter-century....
...Along with striking a co-brand deal with CVS to offer Hyrimoz at a discounted price of $1,315 a month, Sandoz has a higher list price version of the biosimilar, priced similarly to Humira at more than $6,000...
...Oliver Roeder Wyoming is holy ground for hunting. Michela Tindera That’s my colleague Oliver Roeder. He’s a data journalist at the FT. Oliver Roeder There’s a lot of animals there....
...Novavax’s US-listed shares were trading at $10.31 before the New York open, a rise of more than 130 per cent, giving it a market value of about $1.4bn....
...The vaccine maker has undertaken a $1.1bn cost-cutting drive in the past year to stave off a possible bankruptcy and has faced pressure from an activist investor for a board shake-up....
...I’m Rob Armstrong in New York and I’m joined today by Josh Oliver in London....
...Labour leader Sir Keir Starmer hailed “a very, very good set of results”, while one Conservative official lamented “a gloomy, gloomy, gloomy mood” in the party....
...It marks a stunning reversal for Trump, who exited the White House in 2021 with a record-low approval rating of 29 per cent after a mob of his supporters stormed the Capitol on January 6 in a bid to overturn...
...Oliver Roeder is the FT’s US senior data journalist Follow @FTMag to find out about our latest stories first and subscribe to our podcast Life and Art wherever you listen Letter in response to this article...
...Cybin will also initiate its late-stage trial looking at a psilocybin analogue as a treatment for major depressive disorder....
...Total loan origination during the year was £33bn, the lowest in a decade, according to a closely followed report by Bayes Business School....
...Oliver Roeder is the FT’s US senior data journalist Cartography by Steven Bernard and Sam Learner....
International Edition